ScinoPharm Taiwan Market Cap

ScinoPharm Taiwan has a market cap or net worth of 13.52 billion as of June 27, 2025. Its market cap has decreased by -39.25% in one year.

Market Cap

13.52B

Enterprise Value

11.12B

Revenue

3.21B

Ranking

n/a

PE Ratio

55.13

Stock Price

17.55

Market Cap Chart

Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 13.52B, a decrease of -55.57%. That is a compound annual growth rate of -5.38%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	13.88B	-20.41%
Dec 31, 2024	17.44B	-16.48%
Dec 29, 2023	20.88B	3.73%
Dec 30, 2022	20.12B	3.25%
Dec 30, 2021	19.49B	-14.56%
Dec 31, 2020	22.81B	8.46%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	195.43B
PharmaEssentia	183.96B
Bora Pharmaceuticals Co., LTD.	83.99B
Lotus Pharmaceutical	57.85B
Oneness Biotech	31.37B
Polaris Group	30.28B
Center Laboratories	27.17B
Lumosa Therapeutics	25.41B

Market Cap Rankings